NUCLEAR-CYTOPLASMIC TRANSPORT IS A THERAPEUTIC TARGET IN MYELOFIBROSIS

PURPOSE: Myelofibrosis (MF) is a hematopoietic stem cell neoplasm characterized by bone marrow reticulin fibrosis, extramedullary hematopoiesis, and frequent transformation to acute myeloid leukemia. Constitutive activation of JAK/STAT signaling through mutations in JAK2, CALR, or MPL is central to...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Cancer Res
Main Authors: Yan, Dongqing, Pomicter, Anthony D., Tantravahi, Srinivas K., Mason, Clinton C., Senina, Anna V., Ahmann, Jonathan M., Wang, Qiang, Than, Hein, Patel, Ami B., Heaton, William L., Eiring, Anna M., Clair, Phillip M., Gantz, Kevin C., Redwine, Hannah M., Swierczek, Sabina I., Halverson, Brayden J., Baloglu, Erkan, Shacham, Sharon, Khorashad, Jamshid S., Kelley, Todd W., Salama, Mohamed E., Miles, Rodney R., Boucher, Kenneth M., Prchal, Josef T., O'Hare, Thomas, Deininger, Michael W.
Format: Artigo
Jezik:Inglês
Izdano: 2018
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6445677/
https://ncbi.nlm.nih.gov/pubmed/30563936
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-18-0959
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki